Various studies have demonstrated that NOS inhibitors such as NG-nitroarginine methyl ester (L-NAME, nonspecific NOS inhibitor) and 7-Nitroindazole (7-NI, selective nNOS inhibitor) have shown to mitigate the neuroadaptive changes associated with morphine dependence [19]. This evidence concerns the gene NOS2 and substance dependence.